India Orders Bayer to License a Patented Drug
►http://www.nytimes.com/2012/03/13/business/global/india-overrules-bayer-allowing-generic-drug.html
India’s government on Monday authorized a drug manufacturer to make and sell a generic copy of a patented Bayer cancer drug, saying that Bayer charged a price that was unaffordable to most of the nation.